Literature DB >> 11691544

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

S C Smith, S N Blair, R O Bonow, L M Brass, M D Cerqueira, K Dracup, V Fuster, A Gotto, S M Grundy, N H Miller, A Jacobs, D Jones, R M Krauss, L Mosca, I Ockene, R C Pasternak, T Pearson, M A Pfeffer, R D Starke, K A Taubert.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11691544     DOI： 10.1016/s0735-1097(01)01682-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  40 in total

Review 1.  Isoprenoid metabolism and the pleiotropic effects of statins.

Authors:  Ulrich Laufs; James K Liao
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  Screening asymptomatic low-risk individuals for coronary heart disease: issues and controversies.

Authors:  Leslee J Shaw; Roger S Blumenthal; Paolo Raggi
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

3.  Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points.

Authors:  Gina P Kwon; Jamie L Schroeder; Marcelo J Amar; Alan T Remaley; Robert S Balaban
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

Review 4.  Epidemiologic guidance with coronary artery calcium scoring.

Authors:  Paolo Raggi; Leslee J Shaw
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

5.  Modifications of coronary risk factors.

Authors:  Jeanine Albu; Sheldon H Gottlieb; Phyllis August; Richard W Nesto; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2006-04-19       Impact factor: 2.778

6.  Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association.

Authors:  Nancy T Artinian; Gerald F Fletcher; Dariush Mozaffarian; Penny Kris-Etherton; Linda Van Horn; Alice H Lichtenstein; Shiriki Kumanyika; William E Kraus; Jerome L Fleg; Nancy S Redeker; Janet C Meininger; Joanne Banks; Eileen M Stuart-Shor; Barbara J Fletcher; Todd D Miller; Suzanne Hughes; Lynne T Braun; Laurie A Kopin; Kathy Berra; Laura L Hayman; Linda J Ewing; Philip A Ades; J Larry Durstine; Nancy Houston-Miller; Lora E Burke
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

Review 7.  "Obesity paradox" in coronary artery disease.

Authors:  Ibrahim Akin; Christoph A Nienaber
Journal:  World J Cardiol       Date:  2015-10-26

8.  Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.

Authors:  Dimas T Ikeoka; Carolina Z Vieira; Pedro A Lemos; Tania V Strabelli; Expedito E Ribeiro da Silva; Marco A Perin; Andrea Groselj-Strele; Beate Tiran; Andreas Tiran; Bruno Caramelli
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

9.  Does administration of eicosapentaenoic acid increase soluble thrombomodulin level in statin-treated patients with stable coronary artery disease?

Authors:  Shigemasa Tani; Rei Matsuo; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2018-08-24       Impact factor: 2.037

Review 10.  The role of omega-3 fatty acids in cardiovascular disease.

Authors:  Clemens von Schacky
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.